Apax Is Said to Pick Nomura, UBS for Sale of Insurer Gamalife

Apax Partners has reportedly appointed Nomura Holdings Inc. and UBS Group AG to arrange the potential sale of its European life insurance consolidator, Gamalife, targeting a valuation of approximately €600 million ($703 million). The asset has garnered interest from other private equity firms and insurance companies, indicating an anticipated significant M&A event within the insurance sector.

Analysis

Private equity firm Apax Partners is reportedly initiating a sale process for its European life insurance consolidator, Gamalife, targeting a valuation of approximately €600 million. The appointment of Nomura Holdings Inc. and UBS Group AG to manage the transaction represents a significant mandate win for both investment banks, signaling an active M&A environment. The stated interest from other private equity firms and insurance companies suggests a potentially competitive bidding process, which could support Apax's valuation target. This event underscores a key trend in the European financial sector: private equity firms seeking to exit specialized insurance assets, and the continued appeal of life insurance consolidation platforms for both strategic and financial buyers. The successful execution of this sale will serve as a relevant data point on current asset valuations and liquidity within the private markets.

Key Decisions for Investors

• Investors in Nomura (NMR) and UBS Group (UBS) should view this mandate as a positive indicator of their investment banking divisions' deal flow and fee-generating capabilities in the European M&A market.
• The potential sale of Gamalife serves as a barometer for private equity exit valuations; investors should monitor the final transaction price relative to the €600 million target to gauge the health of the M&A market for financial assets.
• Investors with exposure to the European insurance sector should note the continued interest in life insurance consolidators, as this trend could drive further M&A activity and potentially re-rate valuations for similar assets in the industry.